Functional evidence for an angiotensin IV receptor in rat resistance arteries

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 2, 1999, Pages 583-588

  Loufrani, Laurent ^a   Henrion, Daniel ^a   Chansel, Dominique ^a   Ardaillou, Raymond ^a   Levy, Bernard I ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN II [3-8]; ANGIOTENSIN RECEPTOR; CANDESARTAN HEXETIL; INDOMETACIN; LOSARTAN; N(G) NITROARGININE METHYL ESTER; PHENYLEPHRINE; PROSTAGLANDIN; RECEPTOR SUBTYPE; SEROTONIN;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; ISOLATED ARTERY; MALE; MESENTERIC ARTERY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; RECEPTOR BLOCKING; RESISTANCE BLOOD VESSEL; TACHYPHYLAXIS;

ANIMALS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; DRUG INTERACTIONS; IMIDAZOLES; INDOMETHACIN; LOSARTAN; MALE; MESENTERIC ARTERIES; NG-NITROARGININE METHYL ESTER; PERFUSION; PHENYLEPHRINE; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; SEROTONIN; TACHYPHYLAXIS; TETRAZOLES; VASCULAR RESISTANCE;

EID: 0032695629     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. 2 receptor. Eur J Pharmacol 343:323-331.
2. Champion HC, Garrison EA, Estrada LS, Potter JM and Kadowitz PJ (1996) Analysis of responses to angiotensin I and angiotensin I (3-10) in the mesenteric vascular bed of the cat. Eur J Pharmacol 309:251-259.
3. 1 receptors in the rat. Am J Physiol 274:E115-E123.
4. Champion HC and Kadowitz PJ (1997) Analysis of the effects of candesartan in the mesenteric vascular bed of the cat. Hypertension 30:1260-1266.
5. Chansel D, Czekalski S, Vandermeersch S, Ruffet E, Fournié-Zaluski MC and Ardaillou R (1998) Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells. Am J Physiol 275:F535-F542.
6. Coleman JK, Krebs LT, Hamilton TA, Ong B, Laurence KA, Sardinia MF, Harding JW and Wright JW (1998a) Autoradiographic identification of kidney angiotensin FV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats. Peptides 19:269-277.
7. Coleman JK, Lee JI, Miller JM and Nuttall AL (1998b) Changes in cochlear blood flow due to intra-arterial infusions of angiotensin II (3-8) (angiotensin IV) in guinea pigs. Hear Res 119:61-68.
8. Corriu C, Bernard S, Schott C and Stoclet JC 119951 Effects of losartan on contractile responses of conductance and resistance arteries from rats. J Cardiouasc Pharmacol 28:688-692.
9. Dostal DE, Murakashi T and Peach MJ (1990) Regulation of cytosolic calcium by angiotensins in vascular smooth muscle. Hypertension 15:815-822.
10. Dulin N, Madhun ZT, Chang CH, Berti-Mattera L, Dickens D and Douglas JG (1995) Angiotensin IV receptors and signaling in opossum kidney cells. Am J Physiol 295:F644-F652.
11. Gardiner SM, Kemp A, March JE and Bennett T (1993) Regional haemodynamic effects of angiotensin II (3-8) in conscious rats. Br J Pharmacol 110:159-162.
12. Garrison EA and Kadowitz PJ (1996) Analysis of responses to angiotensin I (3-10) in the hindlimb vascular bed of the cat. Am J Physiol 270:H1172-H1177.
13. Garrison EA, Santiago JA and Kadowitz PJ (1995) Analysis of responses to angiotensin peptides in the hindquarters vascular bed of the cat. Am J Physiol 268: H2425-H2428.
14. Haberl RL (1994) Role of angiotensin receptor subtypes in the response of rabbit brain arterioles to angiotensin. Stroke 25:1476-1480.
15. Hall KL, Hanesworth JM, Ball AE, Felgenhauer GP, Hosick HL and Harding JW (1993) Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV. Regul Pept 44:225-232.
16. Hall KL, Venkateswaran S, Hanesworth JM, Schelling ME and Harding JW (1995) Characterization of a functional angiotensin IV receptor on coronary microvascular endothehal cells. Regul Pept 58:107-115.
17. Halpern W, Osol G and Coy GS (1984) Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system. Ann Biomed Eng 12:463-479.
18. Henrion D, Dechaux E, Dowell FJ, Maclouf J, Samuel JL, Lévy BI and Michel JB (1997a) Alteration of flow-induced dilation in mesenteric resistance arteries of L-NAME treated rats is partially associated to induction of cyclooxygenase-2. Br J Pharmacol 121:83-90.
19. Henrion D, Terzi F, Matrougui K, Duriez M, Boulanger C, Colucci-Guyon E, Babinet C, Briand P, Friedlander G, Poitevin P and Lévy BI (1997b) Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin. J Clin Invest 100:2909-2914.
20. 4 receptor subtypes. Regul Pept 68:131-1387.
21. Kramar EA, Krishman R, Harding JW and Wright JW (1998) Role of nitric oxide in angiotensin IV-induced increases in cerebral blood flow. Regul Pept 74:185-192.
22. Lambert DG, Champion HC and Kadowitz PJ (1998) Inhibitory effect of candesartan on responses to angiotensin peptides in the hindquarters vascular bed of the cat. Can J Physiol Pharmacol 76:133-140.
23. Li Q, Feenstra M, PlaffendorfM, Busman L and van Zwieten PA (1997) Comparative vasoconstrictor effects of angiotensin II, III and IV in human isolated saphenous vein. J Cardiovasc Pharmacol 29:451-456.
24. Matrougui K, Maclouf J, Levy BI and Henrion D (1997) Impaired nitric oxide- and prostaglandin-mediated response to flow in resistance arteries of hypertensive rats. Hypertension 30:942-947.
25. Nishikawa K, Naka T, Chatani F and Yoshimura Y (1997) Candesartan cilexetil: A review of its preclinical pharmacology. J Hum Hypertens 11:S9-S17.
26. Nossaman BD, Feng CJ, Raye AD and Kadowitz PJ (1995) Analysis of responses to Ang IV: Effects of PD-123319 and DUP-753 in the pulmonary circulation of the rat. Am J Physiol 268:L302-L308.
27. Noveri L, Stromberg C and Saavedra JM (1994) Angiotensin IV reverses the acute cerebral blood flow reduction after experimental subarachnoid hemorrhage in the rat. J Cereb Blood Flow Metab 14:1096-1099.
28. Patel JM, Martens JR, Li YD, Gelband CH, Raizada MK and Block ER (1998) Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation. Am J Physiol 275:L1061-H068.
29. Riva L and Galzin AM (1996) Pharmacological characterization of a specific binding site for angiotensin IV in cultured porcine aortic endothelial cells. Eur J Pharmacol 305:193-199.
30. Shibouta Y, Inada Y, Qjima M, Wada T, Noda M, Sanada T, Kubo K, Kohara Y, Naka T and Nishikawa K (1993) Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[(2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole- 7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl-2-ethoxy-l-[[2′-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-ltf-benzimidazole-7-carboxylate(TCV-116).J Pharmacol Exp Ther 266: 114-120.
31. Yoshida M, Kikukawa M, Hisa H and Satoh S (1996) Modulation by nitric oxide and prostaglandin of the renal vascular response to angiotensin II (3-8). Br J Pharmacol 117:885-890.